Nonparaneoplastic autoimmune cerebellar ataxias
Opportunity Pathways - GLP-1 Diabetes Treatment Drugs Market The GLP-1 diabetes treatment drugs market represents one of the most explosive pharmaceutical opportunities of the decade, with the market projected to surge from USD 6,556.5 million in 2025 to USD 62,543.2 million by 2035 at an extraordinary 25.3% CAGRa 9.5X expansion driven by the global diabetes epidemic, breakthrough efficacy data, and expanding therapeutic applications beyond glucose control to include weight management and cardiovascular protection
This forms the basis for NICE recommendations that weight management should be a first-line intervention for individuals with obesity who are experiencing fertility difficulties
Clean the skin, use the correct needle length, insert at 90, and do not inject into subcutaneous fat by mistake
The research "MOTILITY - Metabolism Of inTersectIonaLITY starts from this metaphor, to investigate mainstream discourses on Urban Metabolism (UM), Sustainable Development (SD) and Circular Economy (CE), recently criticized for being focused on technological issues, neglecting spatial and social justice, and thereby not considering the need for social and systemic changes (Agyeman, 2005